Last reviewed · How we verify

NCT04461561: ELNEC-PPC

Using NPT to Evaluate Providing PPC as ELNEC-PPC WBT for Nurses

Status unknown NA Last updated 27 July 2020
What this trial tests

NA trial testing end-of-life nursing education consortium-pediatric palliative care as web based-training plus usual care in Cancer in 172 participants. Status unknown.

Timeline
1 July 2020
Primary endpoint
30 December 2020
1 September 2021

Quick facts

Lead sponsorAltoosi University College
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment172
Start date1 July 2020
Primary completion30 December 2020
Estimated completion1 September 2021
Sites1 location across Iraq

Drugs / interventions tested

Conditions studied

Sponsor

Altoosi University College

Who can join

Adults 20 to 65, any sex, with Cancer or Cardiac Anomaly. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to explain the provision of palliative care at the end of life by the implementation of the ELNEC course, as WBT Program using the Normalization Process Theory, that focus attention on how complex interventions become routinely embedded in practice. In addition to, identify the changes implemented by the participant nurses (intervention group) in their clinical practice, after participating in WBT Program to provide Palliative Care alongside with usual care versus usual care only (control group) for children with life-limiting conditions or in the case of accidents/sudden death, at the end of life. And finally, provide findings that will assist in the interpretation of the trial results.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Using Normalization Process Theory to Evaluate an End-of-Life Pediatric Palliative Care Web-Based Training Program for Nurses: Protocol for a Randomized Controlled Trial.
    Al-Shammari MA, Yasir A, Aldoori N, Mohammad H. · · 2022 · PMID 36367759 · DOI 10.2196/23783

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04461561.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing